DE60014064D1 - Einetenascin-c isoform als marker für neoplasmen - Google Patents

Einetenascin-c isoform als marker für neoplasmen

Info

Publication number
DE60014064D1
DE60014064D1 DE60014064T DE60014064T DE60014064D1 DE 60014064 D1 DE60014064 D1 DE 60014064D1 DE 60014064 T DE60014064 T DE 60014064T DE 60014064 T DE60014064 T DE 60014064T DE 60014064 D1 DE60014064 D1 DE 60014064D1
Authority
DE
Germany
Prior art keywords
isoform
einetenascin
neoplasms
marker
ctn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60014064T
Other languages
English (en)
Other versions
DE60014064T2 (de
Inventor
Luciano Zardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philogen SpA
Original Assignee
Philogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philogen SpA filed Critical Philogen SpA
Application granted granted Critical
Publication of DE60014064D1 publication Critical patent/DE60014064D1/de
Publication of DE60014064T2 publication Critical patent/DE60014064T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
DE60014064T 1999-04-20 2000-04-19 Einetenascin-c isoform als marker für neoplasmen Expired - Lifetime DE60014064T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITFI990094 1999-04-20
IT1999FI000094A IT1307864B1 (it) 1999-04-20 1999-04-20 Metodo diagnostico per il riconoscimento di neoplasie umane attraversola determinazione dell'isoforma ctn-c della tn-c, frammenti di
PCT/EP2000/003550 WO2000063699A1 (en) 1999-04-20 2000-04-19 A tenascin-c isoform as a marker for neoplasias

Publications (2)

Publication Number Publication Date
DE60014064D1 true DE60014064D1 (de) 2004-10-28
DE60014064T2 DE60014064T2 (de) 2006-02-23

Family

ID=11352932

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014064T Expired - Lifetime DE60014064T2 (de) 1999-04-20 2000-04-19 Einetenascin-c isoform als marker für neoplasmen

Country Status (11)

Country Link
US (1) US7109301B1 (de)
EP (1) EP1173766B1 (de)
JP (1) JP4577665B2 (de)
AT (1) ATE277352T1 (de)
AU (1) AU779015B2 (de)
CA (1) CA2370666C (de)
DE (1) DE60014064T2 (de)
DK (1) DK1173766T3 (de)
ES (1) ES2226823T3 (de)
IT (1) IT1307864B1 (de)
WO (1) WO2000063699A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317108B1 (it) * 2000-12-06 2003-05-26 Philogen Srl Processo per la selezione di frammenti anticorporali anti-angiogenesi,frammenti anticorpali anti-angiogenesi cosi' ottenuti e loro uso.
CA2446734A1 (en) * 2001-05-24 2002-11-28 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (april)
EP1446416A4 (de) * 2001-11-19 2005-11-30 Applied Molecular Evolution Tumorspezifische monoklonale antikörper
DE602005014665D1 (de) * 2004-11-09 2009-07-09 Philogen Spa Antikörper gegen tenascin-c
LT2757091T (lt) 2008-04-01 2017-09-11 Biosearch Technologies, Inc. Stabilizuotos nukleorūgšties tamsūs kvenčerio-fluoroforo zondai
BR112013002444A2 (pt) 2010-08-13 2016-05-24 Roche Glycart Ag anticorpo, polinucleotídeo e polipeotídeo isolados, composição, vetor, cécula hospedeira, conjulgado de anticorpo, formulação farmacêutica, uso do anticorpo, métodos para produzir um anticorpo, tratar um indivíduo, induzir a lise celular de uma célula tumorosa e diagnosticar uma doença em um indivíduo
WO2017194442A1 (en) 2016-05-11 2017-11-16 F. Hoffmann-La Roche Ag Antigen binding molecules comprising a tnf family ligand trimer and a tenascin binding moiety
EP3455252B1 (de) * 2016-05-11 2022-02-23 F. Hoffmann-La Roche AG Modifizierte anti-tenascin-antikörper und verfahren zur verwendung
GB201621806D0 (en) 2016-12-21 2017-02-01 Philogen Spa Immunocytokines with progressive activation mechanism
CN110382542B (zh) 2017-03-29 2023-06-09 豪夫迈·罗氏有限公司 针对共刺激性tnf受体的双特异性抗原结合分子
CN107058596A (zh) * 2017-06-19 2017-08-18 上海市第十人民医院 一种与恶性胶质瘤诊断相关的标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8547291A (en) * 1990-09-05 1992-03-30 Wistar Institute, The Monoclonal antibodies against tenascin
JPH0643167A (ja) * 1992-04-06 1994-02-18 Amano Pharmaceut Co Ltd 癌マーカーであるテネイシン及びその定量法
HU220347B (hu) * 1994-07-11 2001-12-28 Board Of Regents The University Of Texas System Készítmény az érrendszer specifikus koagulálásához
JPH10505750A (ja) * 1994-09-16 1998-06-09 ザ スクリップス リサーチ インスティテュート 粘着および軸索の成長を刺激するサイトタクチン誘導体並びにその製造および使用方法
JP3850492B2 (ja) * 1996-08-23 2006-11-29 独立行政法人理化学研究所 テネイシン誘導因子

Also Published As

Publication number Publication date
AU4401500A (en) 2000-11-02
CA2370666C (en) 2010-06-01
DK1173766T3 (da) 2005-01-31
CA2370666A1 (en) 2000-10-26
DE60014064T2 (de) 2006-02-23
EP1173766A1 (de) 2002-01-23
ES2226823T3 (es) 2005-04-01
US7109301B1 (en) 2006-09-19
ATE277352T1 (de) 2004-10-15
IT1307864B1 (it) 2001-11-19
WO2000063699A1 (en) 2000-10-26
AU779015B2 (en) 2005-01-06
EP1173766B1 (de) 2004-09-22
JP2002542486A (ja) 2002-12-10
JP4577665B2 (ja) 2010-11-10
ITFI990094A1 (it) 2000-10-20
ITFI990094A0 (it) 1999-04-20

Similar Documents

Publication Publication Date Title
ATE438719T1 (de) Spezifischer marker für prostatakrebs
CY1112458T1 (el) Ενα αντισωμα ειδικο για διαλυτο baff για χρηση στην αντιμετωπιση του καρκινου
DK0914155T3 (da) Monoklonale antistoffer, der er spepcifikke for det ekstracellulære domæne af prostataspecifikt membran-antigen
MXPA04006517A (es) Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores.
EE200100465A (et) Antikehade radioaktiivse märgistamise komplekt jaseostamistest
ATE432986T1 (de) Menschlicher rezeptor für tumor necrosis factor
BRPI9912227B8 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
DE602004019812D1 (de) Marker für neuromyelitis optica
DE60140738D1 (de) Antikörpermoleküle mit spezifizität für menschlichen tumornekrosefaktor-alpha, und deren verwendung
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
BR0112644A (pt) Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
CY1108540T1 (el) Ταυτοποιηση θεραπευτικων ενωσεων
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
DE50207866D1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
DE60032784D1 (de) Markerproteine für prostatakrebs
FR2806739B1 (fr) Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
ATE230761T1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
WO2001096599A3 (en) Methods for quantitative determination of b-fibronectin in biological fluids and tissues
ATE299739T1 (de) Neurokinin b vorläufer aus menschlicher plazenta
ATE256682T1 (de) Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation
DE60333820D1 (de) Konjugate mit einem für die ed-b-domäne von fibronectin spezifischen antikörper, und deren verwendung zum nachweis und zur behandlung von tumoren
UA40839A (uk) Спосіб визначення ступеня сприйняття психологічного впливу у осіб чоловічої статі шляхом психохарактерологічного тестування

Legal Events

Date Code Title Description
8364 No opposition during term of opposition